"Reasonable care" when it comes to Intellectual Property Rights of a product?

1. How can you show "reasonable care" when it comes to Intellectual Property Rights of a product? 2.What is the difference between Asset-based and Non-asset based providers? Provide a short example. 3.In 200 words or more: Discuss the concepts of INFORMED COMPLIANCE and SHARED RESPONSIBILITY. Who is involved in these two concepts, and what roles do they play? What tools/mechanisms are in place for you (the importer) to be able to remain compliant with existing importing requirements? Why is it important to be compliant as an importer?